The DOI matches its Crossref record.
Blood Substitutes: Principles, Methods, Products and Clinical Trials: Vol. 1: Tissue Engineering
Abstract
Part I Present status of substitutes in phase II and phase III clinical trials: donor uses in surgery and the potential for blood substitues the clinical development of human polymerized haemoglobin and HemAssist (DCLHb) - potentially a complementary therapeutic team Hemolink, an o-Raffinose crosslinked haemoglobin-based oxygen carrier overview of preclinical and clinical efficacy of biopure's HBOC's fluorocarbon-based oxygen-delivery - basic principles and product development perfluorochemical emulations - future alternatives to transfusion. Part II Future generations of substitutes: cell-free haeomoglobin and tissue oxidants - probing the mechanisms of haemoglobin cytotoxicity crosslinked haeomglobin-superoxide dismutase-catalase - a second generation haeomoglobin based substitute with antioxidant activities lipsome delivery of haemoglobin - molecular and cellular interactions in the vascular pool nanoencapsulation of haemoglobin and red cell enzymes based on nanotechnology and biodegradable polymer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Riess, J. G. (2001) · Chemical Reviews · doi:10.1021/cr970143c · Cited by 773
Redox Reactions of Hemoglobin and Myoglobin: Biological and Toxicological Implications
Alayash, A. I., Patel, R. P., & Cashon, R. E. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601300185250 · Cited by 243
Metadata
- Authors
- Chang, T. M. S.
- Venue
- KARGER eBooks
- Publisher
- S. Karger AG
- Published
- 1997-10-08
- OpenAlex
- W593425207
- Cited by
- 189
- References
- 0
- FWCI
- 12.14
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blood Substitutes: Principles, Methods, Products and Clinical Trials: Vol. 1: Tissue Engineering. https://app.cochat.ai/papers/10.1159/isbn.978-3-8055-6584-4
- The paper
- Chang, T. M. S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials: Vol. 1: Tissue Engineering. KARGER eBooks. https://doi.org/10.1159/isbn.978-3-8055-6584-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.